Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT05123625Not ApplicableRecruiting
Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC
Bladder Cancer
StudychairStart date: 2021-07-01
NCT02716961Not ApplicableUnknown
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
Bladder CancerEpirubicin InstillationGemcitabine and Cisplatin Chemotherapy+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The First Affiliated Hospital with Nanjing Medical University

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05123625Not ApplicableStudyChair

Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC

Bladder Cancer
Recruiting
NCT02716961Not ApplicablePrincipalInvestigator

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Bladder CancerEpirubicin InstillationGemcitabine and Cisplatin Chemotherapy+2 more
Unknown

All 2 trials loaded